Recruitment

Recruitment Status
Recruiting
Estimated Enrollment
Same as current

Summary

Conditions
Endometrial Cancer
Type
Interventional
Phase
Phase 3
Design
Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: Double (Participant, Investigator)Primary Purpose: Treatment

Participation Requirements

Age
Between 18 years and 125 years
Gender
Only males

Description

Not Provided

Not Provided

Tracking Information

NCT #
NCT03603184
Collaborators
Hoffmann-La Roche
Investigators
Principal Investigator: Nicoletta Colombo, MD Istituto Europeo di Oncologia (IEO) - Milan